)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
Keros Therapeutics
Keros Therapeutics (KROS) investor relations material
Keros Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary22 Apr, 2026
Executive summary
Annual Meeting scheduled for June 3, 2026, at 11:00 A.M. ET, to be held virtually.
Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online for review and voting.
Stockholders can request paper or email copies of proxy materials at no charge before May 26, 2026.
Voting matters and shareholder proposals
Election of two Class III director nominees, Jean-Jacques Bienaimé and Charles Newton, to serve until the 2029 Annual Meeting.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve executive compensation as disclosed in the Proxy Statement.
Board recommends voting "FOR" all nominees and proposals.
Board of directors and corporate governance
Board of Directors' Audit Committee selected Deloitte & Touche LLP as the external auditor for 2026.
Two director nominees are up for election to serve five-year terms.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Keros Therapeutics
- Strategic realignment prioritized rinvatercept, returned $375M to shareholders, and refreshed governance.KROS
Proxy filing22 Apr 2026 - Elritercept advanced with Takeda, rinvatercept moved into DMD/ALS, and pipeline growth is expected.KROSLeerink Global Healthcare Conference 202610 Mar 2026
- 2025 net income reached $87M, reversing prior losses, as license revenue offset lower R&D costs.KROSQ4 20254 Mar 2026
- Rinvatercept advances in DMD and ALS with strong data and strategic Takeda partnership.KROSTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Rinvatercept and elritercept advance in key trials, with strong cash runway into 2028.KROSOppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
- Elritercept shows durable efficacy in MDS and MF, supporting phase 3 advancement.KROSStatus Update3 Feb 2026
- Multiple late-stage trials advance in MDS, PAH, and obesity, with pivotal data expected in 2025.KROSGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Advancing differentiated clinical programs in PAH, MDS, and myelofibrosis with strong financial runway.KROSMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
- KER-012 and KER-050 advance with differentiated safety, while KER-065 targets muscle and metabolism.KROS2024 Wells Fargo Healthcare Conference22 Jan 2026
Next Keros Therapeutics earnings date
Q1 20266 May, 2026
Keros Therapeutics
Next Keros Therapeutics earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage